Is PCRX a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Pacira Biosciences Inc (PCRX) is (36.70) USD. With the latest stock price at 24.54 USD, the upside of Pacira Biosciences Inc based on DCF is -249.5%. This means that PCRX is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.7% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (120.05) - (24.67) | (36.70) |
| Upside | -589.2% - -200.5% | -249.5% |